Stay updated with the latest news and articles about COVAXIN.
In the study, the researchers who were working to know the feasibility of using a different vaccine doss for the prime vaccination than the one used for the booster vaccination, discovered that mixing the doses of two different vaccines could generate stronger immunity.
Covishield has been an important part of the international COVAX alliance, the vaccines with this initiative meed to have the WHO’s approval and on the other side, the Green Pass initiative was based on the EMA’s approval.
The COVAXIN is an inactive vaccine that is developed by chemically treating the novel coronavirus samples to make it incapable of reproduction. That process leave the viral proteins intact, also including the spike protein of the coronavirus which it uses to enter the human cells.
A government panel, on Thursday, has suggested that the interval between two doses of Covishield can be extended to 12-16 weeks. Well, this is the second time in three months that the interval has been extended.
The maker of the COVAXIN, Bharat Biotech had said that it is deeply concerned with the critical pandemic circumstances that India is facing at this time.
Around 50 per cent of the doses produced by vaccine makers will be provided “in the open market”.
"International cooperation is not a one-way street- where we give to others and short change ourselves, I think people need to understand that," said EAM.
Despite having received both the doses of the vaccine, many contracted Covid-19. But, still encourage people to get jab; Here’s why.
Showing 30 of 45 articles